ANGIOSARCOMA
Clinical trials for ANGIOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new ANGIOSARCOMA trials appear
Sign up with your email to follow new studies for ANGIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo for blocking blood vessels shows safety in tumors and malformations
Disease control CompletedThis study looked at the safety of using a contrast agent called Lipiodol Ultra Fluid together with surgical glues to block blood vessels in people with certain vascular lesions or tumors. A total of 132 adults took part. The goal was to see if this combination caused any side ef…
Matched conditions: ANGIOSARCOMA
Phase: PHASE4 • Sponsor: Guerbet • Aim: Disease control
Last updated May 17, 2026 05:35 UTC
-
New hope for rare cancer: drug combo shows promise in angiosarcoma trial
Disease control CompletedThis study tested whether adding a targeted drug called bevacizumab to standard chemotherapy (paclitaxel) helps control advanced angiosarcoma, a rare cancer of blood vessels. About 70 adults with inoperable or metastatic disease took part. The main goal was to see how many patien…
Matched conditions: ANGIOSARCOMA
Phase: PHASE2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated May 08, 2026 12:04 UTC